Greenville Health System, Institute for Translational Oncology Research

Greenville, South Carolina 29605

0 studies enrolling now · 7 studies all time

What they study most

AML, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Advanced Solid Neoplasm, Advanced Solid Tumors, Any Tumor Type Eligible for Treatment With Talimogene Laherparepvec in Amgen or BioVEX-sponsored Clinical Trial, Breast Cancer, Colorectal Cancer, Esophagogastric Cancer, MDS, Neoplasms Malignant, Non-small Cell Lung Cancer

Studies at this site

• Studying An Investigational Drug Crizotinib (PF-02341066) In Non Non-Small Cell Lung Cancer Tumors That Are Positive For Anaplastic Lymphoma Kinase (ALK) — Stopped early
• A Study of TAS-116 in Patients With Solid Tumors — Completed
• A Study to Evaluate the Effects of Rifampin on Pharmacokinetics (PK) of Pevonedistat in Participants With Advanced Solid Tumors — Completed
• Study of APVO436 in Patients With AML or MDS — Status unconfirmed
• Registry Study for Talimogene Laherparepvec — Completed
• Study to Evaluate the Safety and Tolerability of Andecaliximab as Monotherapy and in Combination With Chemotherapy in Participants With Advanced Solid Tumors — Completed
• Study of ADCT-301 in Patients With Relapsed/Refractory CD25-positive Acute Myeloid Leukemia (AML) or CD25-positive Acute Lymphoblastic Leukemia (ALL) — Stopped early